Elsevier has announced that ClinicalPath, its oncology decision support solution, has been designated a Recognized Quality Solution (RQS) by the Association for Clinical Oncology for the ASCO Certified program. The designation highlights ClinicalPath’s alignment with ASCO Certified standards and its role in supporting high‑quality, patient‑centered cancer care.
Omry Bigger, President of Clinical Solutions at Elsevier, noted that the recognition reinforces confidence in the value ClinicalPath provides to cancer practices. He emphasized that the ability to support practices with reporting requirements is a key element of the RQS designation and described the recognition as an important step forward for customers.
Clifford A. Hudis, CEO of ASCO, stated that ClinicalPath underwent a rigorous validation process reviewing data elements for clinical quality measurement and pathway utilization. He indicated that the designation reflects Elsevier’s commitment to assisting practices in meeting certification requirements.
ClinicalPath enables cancer centers to:
• Deliver consistent, patient‑centered care aligned with ASCO Certified standards
• Apply evidence‑based pathways informed by current research, updated content, and integrated clinical trials
• Streamline quality reporting and compliance through automated capture of pathway utilization data
• Strengthen credibility and align with payers by supporting value‑based care models
Click here to read the original press release.
